525 related articles for article (PubMed ID: 16583940)
1. [Medical therapy of benign prostatic hyperplasia].
Altarac S
Lijec Vjesn; 2005; 127(11-12):316-23. PubMed ID: 16583940
[TBL] [Abstract][Full Text] [Related]
2. [Benign prostatic hyperplasia: medical therapy].
Schlenker B; Gratzke C; Weidlich P; Seitz M; Reich O; Stief CG
MMW Fortschr Med; 2007 Aug; 149(33-34):29-31; quiz 32. PubMed ID: 17912863
[TBL] [Abstract][Full Text] [Related]
3. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
4. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
McConnell JD; Roehrborn CG; Bautista OM; Andriole GL; Dixon CM; Kusek JW; Lepor H; McVary KT; Nyberg LM; Clarke HS; Crawford ED; Diokno A; Foley JP; Foster HE; Jacobs SC; Kaplan SA; Kreder KJ; Lieber MM; Lucia MS; Miller GJ; Menon M; Milam DF; Ramsdell JW; Schenkman NS; Slawin KM; Smith JA;
N Engl J Med; 2003 Dec; 349(25):2387-98. PubMed ID: 14681504
[TBL] [Abstract][Full Text] [Related]
5. [Drug therapy for benign prostatic syndrome (BPS)].
Berges R
Aktuelle Urol; 2006 Sep; 37(5):351-62. PubMed ID: 17004180
[TBL] [Abstract][Full Text] [Related]
6. Benign prostatic hyperplasia in older men.
Gerber GS
Clin Geriatr Med; 1998 May; 14(2):317-31. PubMed ID: 9536108
[TBL] [Abstract][Full Text] [Related]
7. [Established and upcoming new options in medical therapy for benign prostatic hyperplasia].
Schlenker B; Beer AM; Gratzke C; Tilki D; Seitz M; Stief CG; Reich O
MMW Fortschr Med; 2009 Oct; 151(41):33-6. PubMed ID: 19891182
[No Abstract] [Full Text] [Related]
8. Medical management of lower urinary tract symptoms in men: current treatment and future approaches.
Patel AK; Chapple CR
Nat Clin Pract Urol; 2008 Apr; 5(4):211-9. PubMed ID: 18301417
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of benign prostatic hyperplasia.
Edwards JL
Am Fam Physician; 2008 May; 77(10):1403-10. PubMed ID: 18533373
[TBL] [Abstract][Full Text] [Related]
10. Finasteride in benign prostatic hyperplasia.
Verhamme KM; Bosch RJ; Sturkenboom MC
N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
[No Abstract] [Full Text] [Related]
11. Benign prostatic hyperplasia--review of treatment options.
Oehlke KJ; Branaugh ML
S D Med; 2009 May; 62(5):202-3. PubMed ID: 19489345
[No Abstract] [Full Text] [Related]
12. Medical management of benign prostatic hyperplasia--are two drugs better than one?
Vaughan ED
N Engl J Med; 2003 Dec; 349(25):2449-51. PubMed ID: 14681512
[No Abstract] [Full Text] [Related]
13. Established medical therapy for benign prostatic hyperplasia.
Auffenberg GB; Helfand BT; McVary KT
Urol Clin North Am; 2009 Nov; 36(4):443-59, v-vi. PubMed ID: 19942044
[TBL] [Abstract][Full Text] [Related]
14. Medical management of benign prostatic hypertrophy.
Nix JW; Carson CC
Can J Urol; 2007 Dec; 14 Suppl 1():53-7. PubMed ID: 18163946
[TBL] [Abstract][Full Text] [Related]
15. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in relation to the patient's risk profile for progression.
Trachtenberg J
BJU Int; 2005 Jun; 95 Suppl 4():6-11. PubMed ID: 15871730
[TBL] [Abstract][Full Text] [Related]
16. Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.
Naslund M; Eaddy MT; Hogue SL; Kruep EJ; Shah MB
Curr Med Res Opin; 2009 Nov; 25(11):2663-9. PubMed ID: 19757985
[TBL] [Abstract][Full Text] [Related]
17. Clinical management of lower urinary tract symptoms with combined medical therapy.
Roehrborn CG
BJU Int; 2008 Nov; 102 Suppl 2():13-7. PubMed ID: 19032605
[No Abstract] [Full Text] [Related]
18. Drug Insight: 5alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia.
Marberger M
Nat Clin Pract Urol; 2006 Sep; 3(9):495-503. PubMed ID: 16964191
[TBL] [Abstract][Full Text] [Related]
19. [Drug treatment of benign prostatic hyperplasia].
Schmid HP
Praxis (Bern 1994); 1995 Sep; 84(39):1061-2. PubMed ID: 7481307
[No Abstract] [Full Text] [Related]
20. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE.
Roehrborn CG
BJU Int; 2008 Mar; 101 Suppl 3():17-21. PubMed ID: 18307681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
